A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models
Ying Jin, Mark L. Chiu(Gwynedd Council)
Cited by 7
Related Papers
A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs
|Pharmaceutics|2025|7
Targeted Hyaluronan Degradation Enhanced Tumor Growth Inhibition in Gastrointestinal Cancer Models
|Cancers|2025|6
Large scale controlled Fab exchange GMP process to prepare bispecific antibodies
|Frontiers in Bioengineering and Biotechnology|2024|5
A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function
|Biochemistry|2024|5